Skip to content
About Us
Events
Resource Library
News
Join
Login
About Us
Events
Resource Library
News
Discover
Why Cancer Nursing?
Cancer Nurses Day
Congress Hub 2026
Member Stories
Consumer Stories
Our Partners
Partner With Us
Advertise With Us
Join
Why Join CNSA?
Membership Categories
Frequently Asked Questions
Learn
Face To Face Events
Webinars
Podcast
Cancer Nursing 101
DIVA Workshops
Webinar Recordings
External Events
Educational Resources
Connect
Annual Congress
Knowledge Sharing and Q&A Forum
Communities of Practice
Specialist Practice Networks
Join a Committee
Research
Australian Journal of Cancer Nursing
Research Pathway
Current Projects
Funding Opportunities
Congress Posters and Abstracts
Research Surveys
Grow
Board Nominations
Jobs Board
Scholarships and Grants
Mentoring Program
Advocate
Workforce
Position Statements
Government Relations
Implement
AusCaN - Australian Cancer Nursing Capability Framework
Vascular access devices for people with cancer
Cancer Nursing Education Portal
Australian Cancer Nursing and Navigation Program
Patient Support Services
Assessment Tools
Radiation Oncology Resources
Survivorship Resources
Join
Login
You are here:
Homepage
Resource Library
Managing Adverse Events associated with Lenvatinib and Pembrolizumab in advanced Endometrial Cancer and Renal Cell Carcinoma
Webinar Recordings
29 November 2023
Managing Adverse Events associated with Lenvatinib and Pembrolizumab in advanced Endometrial Cancer and Renal Cell Carcinoma
Login
Please accept
{{cookieConsents}} cookies
to view this content
